NCT04305366View on ClinicalTrials.gov

MicroRNA Markers in Head and Neck Cancers

Active, not recruitingOBSERVATIONAL
Enrollment

225

Participants

Timeline

Start Date

November 16, 2012

Primary Completion Date

December 20, 2022

Study Completion Date

February 28, 2026

Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
OTHER

Tissue collection

Blood draw, Fine Needle Aspiration, Saliva Swab, Tumor/tissue sample

Trial Locations (1)

80045

University of Colorado Cancer Center, Aurora

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER

NCT04305366 - MicroRNA Markers in Head and Neck Cancers | Biotech Hunter | Biotech Hunter